Humalog contains the active ingredient insulin lispro. The drug comes as a solution for injection under the skin or intravenous (IV) infusion into a vein. Humalog belongs to a group of drugs (drug ...

while a subcutaneous injection is one in the layer of fatty tissue between your skin and muscle. Insulin. Thisis one of the most commonly used drugs that you can inject yourself. This method can ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Sanofi's filing relied, in part, on the FDA’s finding of safety and effectiveness for Humalog (insulin lispro injection) to support approval, but also provided Admelog-specific data, including ...

The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

It is the last bullet point that’s creating issues. During the 2023 Open Enrollment Period, I discovered that some clients’ insulin would not be covered by their plans in the new year.

Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had led to a brief delay in manufacturing ...

Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...